Articles

CD28.OX40 co-stimulatory combination is associated with long in vivo persistence and high activity of CAR.CD30 T-cells

Dept Onco-Haematology, Cell & Gene Therapy, Bambino Gesù Children Hospital, Rome, Italy;
Dept Onco-Haematology, Cell & Gene Therapy, Bambino Gesù Children Hospital, Rome, Italy;
Dept Onco-Haematology, Cell & Gene Therapy, Bambino Gesù Children Hospital, Rome, Italy;
Dept Onco-Haematology, Cell & Gene Therapy, Bambino Gesù Children Hospital, Rome, Italy;
Dept Onco-Haematology, Cell & Gene Therapy, Bambino Gesù Children Hospital, Rome, Italy;
Dept Onco-Haematology, Cell & Gene Therapy, Bambino Gesù Children Hospital, Rome, Italy;
Dept Onco-Haematology, Cell & Gene Therapy, Bambino Gesù Children Hospital, Rome, Italy;
Dept Onco-Haematology, Cell & Gene Therapy, Bambino Gesù Children Hospital, Rome, Italy;
Dept Onco-Haematology, Cell & Gene Therapy, Bambino Gesù Children Hospital, Rome, Italy;
Dept Onco-Haematology, Cell & Gene Therapy, Bambino Gesù Children Hospital, Rome, Italy;
Dept Onco-Haematology, Cell & Gene Therapy, Bambino Gesù Children Hospital, Rome, Italy;
Dept Onco-Haematology, Cell & Gene Therapy, Bambino Gesù Children Hospital, Rome, Italy;
Dept Onco-Haematology, Cell & Gene Therapy, Bambino Gesù Children Hospital, Rome, Italy;
Dept Onco-Haematology, Cell & Gene Therapy, Bambino Gesù Children Hospital, Rome, Italy;
Dept Onco-Haematology, Cell & Gene Therapy, Bambino Gesù Children Hospital, Rome, Italy;
Dept Onco-Haematology, Cell & Gene Therapy, Bambino Gesù Children Hospital, Rome, Italy;
Dept Onco-Haematology, Cell & Gene Therapy, Bambino Gesù Children Hospital, Rome, Italy;
Dept Onco-Haematology, Cell & Gene Therapy, Bambino Gesù Children Hospital, Rome, Italy;
Dept Onco-Haematology, Cell & Gene Therapy, Bambino Gesù Children Hospital, Rome, Italy;
Dept Onco-Haematology, Cell & Gene Therapy, Bambino Gesù Children Hospital, Rome, Italy;
Dept Onco-Haematology, Cell & Gene Therapy, Bambino Gesù Children Hospital, Rome, Italy;
Dept Onco-Haematology, Cell & Gene Therapy, Bambino Gesù Children Hospital, Rome, Italy;
Dept. of Laboratories, Pathology Unit, Bambino Gesù Children Hospital, IRCCS, Rome, Italy;
Genetics and Rare Diseases Research Div, Ospedale Pediatrico Bambino Gesù IRCSS, Rome, Italy;
Genetics and Rare Diseases Research Div, Ospedale Pediatrico Bambino Gesù IRCSS, Rome, Italy;
Genetics and Rare Diseases Research Div, Ospedale Pediatrico Bambino Gesù IRCSS, Rome, Italy;
Department of Immunology, Bambino Gesù Children Hospital, IRCCS, Rome, Rome, Italy
Dept Onco-Haematology, Cell & Gene Therapy, Bambino Gesù Children Hospital, Rome, Italy;
Dept Onco-Haematology, Cell & Gene Therapy, Bambino Gesù Children Hospital, Rome, Italy;
Dept Onco-Haematology, Cell & Gene Therapy, Bambino Gesù Children Hospital, Rome, Italy;
Haematologica Early view May 7, 2020 https://doi.org/10.3324/haematol.2019.231183